R. Piliszek, A. A. Brożyna, W. R. Rudnicki. Computational Analysis Identifies Novel Biomarkers for High-Risk Bladder Cancer Patients. International Journal of Molecular Sciences 23.13: 7057 (2022), DOI: 10.3390/ijms23137057 (140 pkt. MNiSzW) In the case of bladder cancer, carcinoma in situ (CIS) is known to have poor diagnosis. However, there are not enough studies that examine the biomarkers relevant to CIS development. Omics experiments generate data with tens of thousands of…
Tag: biomarkers
New paper!
Moszczuk, B.; Krata, N.; Rudnicki, W.; Foroncewicz, B.; Cysewski, D.; Pączek, L.; Kaleta, B.; Mucha, K. Osteopontin—A Potential Biomarker for IgA Nephropathy: Machine Learning Application. Biomedicines 2022, 10, 734. https://doi.org/10.3390/biomedicines10040734 Abstract Many potential biomarkers in nephrology have been studied, but few are currently used in clinical practice. One is osteopontin (OPN). We compared urinary OPN concentrations in 80 participants: 67 patients with various biopsy-proven glomerulopathies (GNs)—immunoglobulin A nephropathy (IgAN, 29),…